Innovus Pharma Announces the Approval of its Product ProstaGorx in Canada for Benign Prostate Hyperplasia ("BPH")
June 04, 2018 14:46 ET
|
Innovus Pharmaceuticals, Inc.
ProstaGorx is the Ninth Innovus Pharma Product Approved in Canada to Date SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire – Innovus Pharmaceuticals, Inc. ("Innovus Pharma" or the...
Ben R. Chen Joins Atossa Genetics as Senior Vice President of Global Regulatory Affairs and Quality Assurance
April 02, 2014 08:30 ET
|
Atossa Genetics Inc.
SEATTLE, WA--(Marketwired - Apr 2, 2014) - Atossa Genetics, Inc. (NASDAQ: ATOS) announced today that Ben R. Chen has joined the Company as Senior Vice President of Global Regulatory Affairs and...
Atossa Genetics to Exhibit Its ForeCYTE Breast Health Test at the Breast Cancer Symposium 2013
September 06, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 6, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, will display its ForeCYTE Breast Health Test at the 7th annual Breast Cancer...
Atossa Genetics Names Kyle Guse as Chief Financial Officer, General Counsel and Secretary
January 07, 2013 07:00 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwire - Jan 7, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Kyle Guse, 49, has joined the Company as Chief Financial...